ANDA 74946, held by Strides Pharma Intl. Acyclovir.
As of Nov 13, 2026, ANDA 74946 (Acyclovir), held by Strides Pharma Intl, was first approved by FDA on Nov 19, 1997, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 19, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
